Clinical Evaluation of the Use of Exemestane as Further Hormonal Therapy after Nonsteroidal Aromatase Inhibitors in Postmenopausal Metastatic Breast Cancer PatientsPaolo Carlini, Francesco Cognetti, Diana Giannarelli et al.|Cancer Investigation|2007Cited by 36
Phase II, randomized trial of preoperative epirubicin-paclitaxel +/− gefitinib with biomarker evaluation in operable breast cancerValentina Guarneri, PierFranco Conte, Antonio Frassoldati et al.|Breast Cancer Research and Treatment|2007Cited by 21